Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Luxor Capital Discloses 7.0% Stake in Golar LNG

A group of affiliated entities led by Luxor Capital Group, LP filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of common shares in Golar LNG Ltd as of a triggering event dated November 2, 2026.

Nitish Kishor | 09 November 2026

ContextLogic Holdings Posts Q3 2026 Net Loss of $13.4M

ContextLogic Holdings Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 9, 2026, reporting condensed consolidated financial results as a successor entity following a business combination completed in late February 2026.

Shwetambri Chauhan | 09 November 2026

Mereo BioPharma Q3 2026: Cash Falls to $26.1M

Mereo BioPharma Group plc filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting a net cash position of $26.1 million and a widening accumulated deficit.

Anjali Anand | 09 November 2026

Quanterix Posts Q3 2026 Revenue of $34.97M

Quanterix Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting total revenues of $34,974 thousand for the third quarter and $104,295 thousand for the nine months ended September …

Shwetambri Chauhan | 09 November 2026

SS&C Technologies Prices $1.2B Convertible Notes Due 2031

SS&C Technologies Holdings, Inc. filed a Form 8-K on November 9, 2026, disclosing the completion of a $1,200,000,000 aggregate principal amount offering of 2.75% Convertible Senior Notes due 2031, with the transaction closing on November 6, 2026.

Anjali Anand | 09 November 2026

Sonoco Names Haynes CEO as Coker Retires Dec. 31

Sonoco Products Company filed a Form 8-K on November 9, 2026, disclosing the planned retirement of President and CEO R. Howard Coker effective December 31, 2026, the appointment of Ernest D. Haynes III as his successor, and a retention award for Chief Financial Officer …

Aditi Sarkar | 09 November 2026

Innovative Industrial Properties Adds Series B Preferred to ATM Program

Innovative Industrial Properties, Inc. filed a Form 8-K on November 9, 2026, disclosing amendments to its existing equity distribution agreements that add the company's 9.25% Series B Cumulative Redeemable Preferred Stock to its at-the-market offering program.

Manish Choudhary | 09 November 2026

Cellebrite Q3 2026 Call Dial-In Revised Before Nov. 12 Event

Cellebrite DI Ltd. filed an announcement on November 9, 2026, notifying analysts and investors that the call-in number for its third-quarter 2026 financial results conference call had been updated, while all other details for the November 12, 2026 event remained unchanged from the October …

Manish Choudhary | 09 November 2026

K2 Principal Fund Discloses 7.74% Stake in Newbury Street II

A Schedule 13G was filed on November 9, 2026, by The K2 Principal Fund, L.P. and three affiliated entities disclosing beneficial ownership of 241,100 Class A Ordinary Shares of Newbury Street II Acquisition Corp as of November 4, 2026.

Aakashdeep | 09 November 2026

Vir Biotechnology ECLIPSE 1 Phase 3 Trial Meets Primary Endpoint

Vir Biotechnology, Inc. filed a Form 8-K on November 9, 2026, disclosing topline results from its pivotal Phase 3 ECLIPSE 1 clinical trial and expanded Week 96 data from the Phase 2 SOLSTICE study, both evaluating elebsiran and tobevibart in adults with chronic hepatitis …

Aditi Sarkar | 09 November 2026
Support

Hi! How can we help you today?

Loading…